EverQuote stock edges higher as Wall Street Zen cuts rating to Hold

EverQuote stock (ISIN US29977X1063) traded near USD 23 in mid-September 2026, with investors weighing a fresh analyst downgrade alongside continued double-digit revenue growth from the company’s online insurance marketplace.

Wall Street Zen downgrade sets the tone

According to MarketBeat on September 20, 2026, Wall Street Zen lowered its rating on EverQuote from Buy to Hold, even as the broader analyst consensus remains Moderate Buy with an average price target of USD 28.17.

The same overview notes that six investment analysts currently rate the stock Buy, one has a Hold rating and one a Sell rating, underlining that the downgrade is a caution signal rather than a broad shift in sentiment.MarketBeat

Stock price and recent trading range

Per data summarized by MarketBeat, EverQuote shares opened at USD 23.14 on Nasdaq on the most recent completed trading day, which was September 18, 2026.

The same snapshot indicates that EverQuote stock was up around 1.1% in that session, reflecting modest positive momentum as the market digested the rating change and broader insurance-sector dynamics.MarketBeat

Recent fundamentals from Q2 2026

EverQuote, Inc. reported its most recent quarterly figures for the second quarter of 2026 earlier this summer, covering the period that ended June 30, 2026, which falls well within the nine month freshness window for interim results.

According to the company’s Q2 2026 release available via its investor-relations site EverQuote, the online insurance marketplace generated revenue of roughly USD 124 million in Q2 2026, an increase of about 15% compared with the same quarter a year earlier.

The same Q2 2026 statement notes that EverQuote remained loss-making at the bottom line, with a net loss of around USD 6 million in the quarter, which was an improvement of approximately 40% versus the prior-year period as the company tightened costs and focused on higher-value traffic.EverQuote

Management also reiterated guidance for full-year 2026, stating in the Q2 2026 release that it expects continued double-digit revenue growth while working toward breakeven adjusted EBITDA in the second half of the year.EverQuote

Analyst targets vs. current valuation

With EverQuote stock trading around USD 23.14 as of September 18, 2026, the average analyst price target of USD 28.17 implies potential upside of roughly 22% if the company delivers on its growth and margin ambitions.MarketBeat

According to MarketBeat, institutional investors hold about 91.54% of EverQuote’s outstanding shares, and insiders sold 63,024 shares worth approximately USD 1.57 million over the past three months, a data point that some investors may see as a signal of cautious confidence.

For investors, the combined picture is nuanced: Wall Street Zen’s downgrade to Hold introduces a more restrained stance, but the Moderate Buy consensus and double-digit revenue growth support a constructive long-term narrative as long as the path toward profitability continues.

Key risks and upcoming dates

One of the main risks highlighted by EverQuote itself in its Q2 2026 disclosure is the sensitivity of its business to changes in insurance carrier advertising budgets, which can weigh on revenue growth when carriers tighten marketing spend.EverQuote

According to the company’s financial calendar on EverQuote, the next scheduled event is the release of Q3 2026 results in early November 2026, which will give investors a clearer view on whether the trend toward smaller losses and improving margins is sustainable through the remainder of the year.

EverQuote stock price level

EverQuote stock closed at approximately USD 23.14 on Nasdaq on September 18, 2026, with the price quoted in United States dollars for the company’s primary listing; this level stands below the consensus price target of USD 28.17 but reflects a modest 1.1% gain in that last completed session.

More news and analyses on EverQuote stock